Pressure BioSciences, Inc. (OTCMKTS:PBIO – Get Free Report) was the recipient of a large growth in short interest in May. As of May 31st, there was short interest totalling 26,500 shares, a growth of 516.3% from the May 15th total of 4,300 shares. Based on an average daily volume of 66,900 shares, the days-to-cover ratio […]
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report)’s share price fell 4.7% during mid-day trading on Tuesday . The stock traded as low as $21.90 and last traded at $22.12. 111,875 shares traded hands during mid-day trading, a decline of 54% from the average session volume of 240,997 shares. The stock had previously closed at […]
Revelation Biosciences, Inc. (NASDAQ:REVB – Get Free Report) shares rose 13.9% on Wednesday . The company traded as high as $2.24 and last traded at $2.21. Approximately 133,344 shares were traded during mid-day trading, a decline of 46% from the average daily volume of 247,025 shares. The stock had previously closed at $1.94. Revelation Biosciences […]
Forte Biosciences, Inc. (NASDAQ:FBRX – Get Free Report) saw a large drop in short interest in May. As of May 15th, there was short interest totalling 25,100 shares, a drop of 12.8% from the April 30th total of 28,800 shares. Based on an average daily volume of 25,800 shares, the short-interest ratio is currently 1.0 […]
Neurocrine Biosciences (NASDAQ:NBIX – Free Report) had its price objective hoisted by UBS Group from $174.00 to $193.00 in a report issued on Tuesday morning, Benzinga reports. UBS Group currently has a buy rating on the stock. Several other equities research analysts have also recently issued reports on NBIX. Needham & Company LLC reaffirmed a […]